← Open Payments lookup

JENNIFER AMOS: Open Payments

NPI 1043761000 · BEVERLY HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,307 in 53 payments from 8 companies in 2025. Trend: 2023 $1,458 · 2024 $995 · 2025 $1,307

Food & beverage: $1,203Education: $104
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.16$479
Teva Pharmaceuticals USA, Inc.10$250
E.R. Squibb & Sons, L.L.C.10$240
Otsuka America Pharmaceutical, Inc.8$161
Vanda Pharmaceuticals Inc.6$102
Janssen Pharmaceuticals, Inc1$40
PFIZER INC.1$20
Luye Pharma (USA) Ltd.1$15

Products named: INGREZZA, COBENFY, UZEDY, FANAPT, REXULTI, ABILIFY MAINTENA, INVEGA SUSTENNA, NURTEC ODT.

Industry payments across CA — which companies pay providers there.